Paragonix Technologies Secures Official EU MDR Approval for 5 Organ Preservation Devices
Dr. Lisa Anderson, President of Paragonix Technologies. “This achievement validates our technology’s safety and effectiveness while expanding our ability to serve patients and healthcare providers in critical transplant care across the world. With this approval and the support structure provided by Sweden-based Getinge, we are dedicated to setting new standards in organ preservation, advancing the future of transplantation, and making a global impact.”
Chiropractic Treatment for Sciatica: What You Need to Know

Living with sciatica can feel like an uphill battle. Every step and every movement might trigger that sharp, shooting pain. But you’re not alone, and there are gentle, non-invasive options available that many have found helpful. In this guide, we’ll explore how chiropractic treatment for sciatica might be the key to easing your discomfort and […]
Learn More About How An Attorney Can Help Prove Your Cancer Misdiagnosis

Receiving a cancer diagnosis is a life-changing event that can leave you feeling overwhelmed and uncertain about the future. However, when that diagnosis is later revealed to be a misdiagnosis, the emotional and physical toll can be devastating. If you or a loved one has experienced a cancer misdiagnosis, it’s important to know that you […]
BiVACOR Total Artificial Heart Successfully Implanted in First Patient in Australia; TAH in Place Over 100 Days
Following weeks of in-hospital monitoring, the patient was the first in the world to be discharged from the hospital with the BiVACOR Total Artificial Heart as he awaited a heart transplant. After having the device for 105 days, a donor heart became available, and the patient received a heart transplant on March 6, 2025.
What Should Pharmacies Know About Child-Resistant and Senior-Friendly Blister Packaging: Key Considerations and Best Practices

Implementing child-resistant and senior-friendly blister packaging is essential for pharmacies to enhance safety and accessibility. Such packaging significantly reduces the risk of accidental poisoning among children by making it difficult for them to open, while remaining easy for seniors to use.
Innovaderm Research Rebrands as Indero | a Dual-Focus CRO
Indero is a dual-focus CRO for dermatology and rheumatology, with over 25 years of experience in clinical research and trial delivery.
Abbas Kazimi Steps Up as Dynamic CEO of Nimbus Therapeutics
“I am honored to lead Nimbus at this pivotal time in the company’s evolution,” said Abbas Kazimi. “Our robust pipeline, anchored by promising programs like our WRN and SIK inhibitors, and our ongoing collaboration with Lilly, continues to validate our approach and strengthen our position in the industry. I’m particularly excited about what Nimbus will continue to discover and advance, as we leverage our computational drug discovery engine to bring innovative medicines for patients.”
Reflow Medical Expands Global Reach with New European Subsidiary in Landsberg am Lech, Germany
Isa Rizk, Co-Founder and CEO of Reflow Medical. “This presence allows us to better address the needs of international markets by providing direct sales solutions and forming key distribution collaborations. Our goal is to deliver breakthrough technologies that support physicians and improve patient outcomes worldwide.”
COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
Dave Mehalick, CEO of COEPTIS stated, “Partnering with NUBURU marks a significant step in COEPTIS’ journey toward pioneering innovative technology solutions. By harnessing the power of NexGen’s AI-driven capabilities, we are poised to not only enhance our own operational efficiencies but also redefine how businesses engage with their clients in the rapidly evolving defense and security landscape. This collaboration underscores our commitment to fostering growth through advanced technological integrations.”
Mirva Ekman Appointed Quality Director & Member of the Management Team at Bioretec
Mirva Ekman over 20 years of experience in quality and regulatory leadership.
Vitestro Unveils Aletta ™ | World’s 1st Autonomous Robotic Phlebotomy Device

Aletta is the first and only Autonomous Robotic Phlebotomy Device™ (ARPD™), a unique technology descriptor that establishes a new category of medical robotics dedicated to optimizing blood collection. As the exclusive ARPD™, Aletta sets the global industry standard for automated venous blood draws—enhancing clinical precision, safety, efficiency, and patient experience.
Phantom Neuro Receives FDA Breakthrough Device & TAP Designations, Solidifying Position as a Neurotech Leader
“Receiving both of these certified designations from the FDA is a tremendous validation of our work,” said Dr. Connor Glass, Founder and CEO of Phantom Neuro. “These recognitions validate our technology and reflect our commitment to creating scalable, real-world solutions that restore functionality and independence to amputees and those with functional disabilities. Our goal is to bring Phantom X to patients faster, and achievements like this accelerate our clinical and regulatory processes.”